Clinical Trials Browser

Active not recruiting × Liver Neoplasms × Nivolumab × Clear all

NCT04658147 2025-12-18

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Phase 1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03383458 2025-11-21

CheckMate 9DX

Phase 3 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03143270 2025-05-02

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Liver Neoplasms